These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31415245)

  • 1. Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller.
    Migueles SA; Chairez C; Lin S; Gavil NV; Rosenthal DM; Pooran M; Natarajan V; Rupert A; Dewar R; Rehman T; Sherman BT; Adelsberger J; Leitman SF; Stroncek D; Morse CG; Connors M; Lane HC; Kovacs JA
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31415245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
    Tebas P; Jadlowsky JK; Shaw PA; Tian L; Esparza E; Brennan AL; Kim S; Naing SY; Richardson MW; Vogel AN; Maldini CR; Kong H; Liu X; Lacey SF; Bauer AM; Mampe F; Richman LP; Lee G; Ando D; Levine BL; Porter DL; Zhao Y; Siegel DL; Bar KJ; June CH; Riley JL
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elite suppression of HIV-1 replication.
    Blankson JN; Siliciano RF
    Immunity; 2008 Dec; 29(6):845-7. PubMed ID: 19100698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STING Ligand-Mediated Priming of Functional CD8
    Kuse N; Akahoshi T; Takiguchi M
    J Virol; 2021 Jul; 95(16):e0069921. PubMed ID: 34076478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
    Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
    Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.
    Soghoian DZ; Jessen H; Flanders M; Sierra-Davidson K; Cutler S; Pertel T; Ranasinghe S; Lindqvist M; Davis I; Lane K; Rychert J; Rosenberg ES; Piechocka-Trocha A; Brass AL; Brenchley JM; Walker BD; Streeck H
    Sci Transl Med; 2012 Feb; 4(123):123ra25. PubMed ID: 22378925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis.
    Hoffmann C; Stellbrink HJ; Dielschneider T; Degen O; Stoehr A; Knechten H; Wolf E; van Lunzen J
    Br J Haematol; 2007 Feb; 136(4):641-8. PubMed ID: 17223918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
    Deeks SG; Wagner B; Anton PA; Mitsuyasu RT; Scadden DT; Huang C; Macken C; Richman DD; Christopherson C; June CH; Lazar R; Broad DF; Jalali S; Hege KM
    Mol Ther; 2002 Jun; 5(6):788-97. PubMed ID: 12027564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.
    Salgado M; Rabi SA; O'Connell KA; Buckheit RW; Bailey JR; Chaudhry AA; Breaud AR; Marzinke MA; Clarke W; Margolick JB; Siliciano RF; Blankson JN
    Retrovirology; 2011 Dec; 8():97. PubMed ID: 22141397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents.
    Haridas V; McCloskey TW; Pahwa R; Pahwa S
    AIDS; 2003 Nov; 17(16):2313-22. PubMed ID: 14571182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE; Buckheit RW; Blankson JN
    J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
    Brumme Z; Wang B; Nair K; Brumme C; de Pierres C; Reddy S; Julg B; Moodley E; Thobakgale C; Lu Z; van der Stok M; Bishop K; Mncube Z; Chonco F; Yuki Y; Frahm N; Brander C; Carrington M; Freedberg K; Kiepiela P; Goulder P; Walker B; Ndung'u T; Losina E
    Clin Infect Dis; 2009 Sep; 49(6):956-64. PubMed ID: 19663693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Expression of miR-19b Enhances CD8
    Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
    Front Immunol; 2018; 9():3140. PubMed ID: 30687333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.